ATR · Aptargroup, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · ATR

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$3.78B	$3.58B	$3.49B	$3.32B	$3.23B	$2.93B
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	$906.01M
R&D	$105.10M	$96.10M	$92.80M	$93.50M	$99.80M	$92.50M
SG&A	-	-	-	-	-	-
Total Operating Expenses	$3.28B	$3.09B	$3.08B	$2.94B	$2.88B	$2.59B
D&A	$287.36M	$263.78M	$248.59M	$233.71M	$234.85M	$220.30M
Operating Income	$501.04M	$496.50M	$404.02M	$379.27M	$347.35M	$339.50M
Interest Expense	$52.74M	$43.90M	$40.42M	$40.83M	$30.28M	$33.24M
Income Tax	$98.88M	$95.59M	$90.65M	$95.15M	$78.02M	$87.06M
Net Income	$392.79M	$374.54M	$284.49M	$214.04M	$244.10M	$214.04M
EPS - Basic	$5.97	$5.65	$4.34	$3.66	$3.72	$3.32
EPS - Diluted	$5.89	$5.53	$4.25	$3.59	$3.61	$3.21

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$402.42M	$223.84M	$223.64M	$141.73M	$122.92M	$300.14M
Accounts Receivable	-	$658.10M	$677.80M	$677.00M	$671.00M	$567.00M
Inventory	$537.85M	$461.81M	$513.05M	$486.81M	$441.46M	$379.38M
Accounts Payable	$340.56M	$295.97M	$328.57M	$320.28M	$285.26M	$243.74M
Current Assets	$1.89B	$1.48B	$1.55B	$1.43B	$1.36B	$1.37B
Total Assets	$5.25B	$4.43B	$4.45B	$4.20B	$4.14B	$3.99B
Current Liabilities	$1.17B	$1.07B	$1.25B	$917.18M	$982.49M	$780.33M
Long-term Debt	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	$2.67B	$2.47B	$2.31B	$2.05B	$1.97B	$1.85B
Retained Earnings	$2.64B	$2.37B	$2.11B	$1.93B	$1.79B	$1.64B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$570.00M	$643.41M	$575.24M	$478.62M	$363.44M	$570.15M
Investing Cash Flow	($331.43M)	($396.72M)	($324.46M)	($295.64M)	($457.24M)	($451.98M)
Financing Cash Flow	($77.47M)	($225.34M)	($171.55M)	($162.10M)	($81.52M)	($73.72M)
CapEx	$270.42M	$276.48M	$312.34M	$310.43M	$307.94M	$245.95M
Free Cash Flow	$299.58M	$366.93M	$262.90M	$168.19M	$55.51M	$324.20M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	-	-	-	-	-	30.9%
Operating margin	13.3%	13.9%	11.6%	11.4%	10.8%	11.6%
EBITDA margin	20.9%	21.2%	18.7%	18.5%	18.0%	19.1%
Net margin	10.4%	10.5%	8.2%	6.4%	7.6%	7.3%
Free cash flow margin	7.9%	10.2%	7.5%	5.1%	1.7%	11.1%
FCF / Net income	0.76	0.98	0.92	0.79	0.23	1.51
R&D / Revenue	2.8%	2.7%	2.7%	2.8%	3.1%	3.2%
SG&A / Revenue	-	-	-	-	-	-
Effective tax rate	20.1%	20.3%	24.2%	30.8%	24.2%	28.9%
Return on assets	7.5%	8.5%	6.4%	5.1%	5.9%	5.4%
Return on equity	14.7%	15.2%	12.3%	10.4%	12.4%	11.6%
Return on invested capital	-	-	-	-	-	-
Liquidity
Current ratio	1.62	1.38	1.24	1.56	1.38	1.75
Quick ratio	1.16	0.95	0.83	1.03	0.93	1.27
Cash ratio	0.35	0.21	0.18	0.15	0.13	0.38
Leverage
Debt / Equity	-	-	-	-	-	-
Debt / Assets	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Interest coverage	9.5x	11.3x	10.0x	9.3x	11.5x	10.2x
Equity multiplier	1.97	1.79	1.93	2.05	2.10	2.16
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	0.72	0.81	0.78	0.79	0.78	0.73
Inventory turnover	-	-	-	-	-	-
Days sales outstanding	-	67d	71d	74d	76d	71d
Days inventory outstanding	-	-	-	-	-	-
Days payable outstanding	-	-	-	-	-	-
Cash conversion cycle	-	-	-	-	-	-
Valuation
P / E	20.7x	28.4x	29.1x	30.6x	33.9x	42.6x
P / B	3.1x	4.3x	3.6x	3.6x	4.2x	4.9x
P / S	2.2x	3.0x	2.4x	2.2x	2.6x	3.1x
EV / EBITDA	9.8x	13.7x	12.3x	11.7x	14.0x	15.8x
Growth
Revenue growth (YoY)	5.4%	2.7%	5.0%	2.9%	10.2%	2.4%
Revenue CAGR (3y)	4.4%	3.5%	6.0%	5.1%	11.5%	5.9%
Revenue CAGR (5y)	5.2%	4.6%	8.4%	6.1%	6.7%	4.8%
Gross profit growth (YoY)	-	-	-	-	-	3.6%
Operating income growth (YoY)	0.9%	22.9%	6.5%	9.2%	2.3%	-8.7%
Net income growth (YoY)	4.9%	31.7%	32.9%	-12.3%	14.0%	-11.6%
EPS growth (YoY)	6.5%	30.1%	18.4%	-0.6%	12.5%	-12.3%
EPS CAGR (3y)	17.9%	15.3%	9.8%	-0.6%	6.4%	-2.0%
EPS CAGR (5y)	12.9%	8.6%	7.2%	1.0%	2.6%	0.8%
FCF growth (YoY)	-18.4%	39.6%	56.3%	203.0%	-82.9%	19.1%
FCF CAGR (5y)	-1.6%	6.2%	20.8%	-0.1%	-22.5%	13.1%
Book value growth (YoY)	7.9%	7.2%	12.3%	4.3%	6.4%	17.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$3.81B total

Pharma Segment$1.74B · 45.6%

Beauty Segment$1.34B · 35.1%

Closures Segment$736.94M · 19.3%

Geographic

$5.64B total

Europe$1.86B · 33.0%

US$1.07B · 19.0%

Other Europe$788.07M · 14.0%

Other Foreign Countries$648.79M · 11.5%

FR$513.28M · 9.1%

IT$201.90M · 3.6%

ES$195.41M · 3.5%

CN$194.41M · 3.4%

DE$163.91M · 2.9%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

5/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✓Current ratio improved
✓No share dilution
-Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Plastics Products, NEC

Company	Revenue (last FY)	Net margin	ROE
ENTG	$3.20B	7.4%	6.0%
AZEK	-	-	-
NWL	$7.20B	-4.0%	-11.9%
CMT	$273.80M	4.1%	7.1%
SWIM	$545.91M	2.0%	2.7%

Comparing APTARGROUP against the 5 most active filers in the same SIC group.

Dividends

$1.89/share trailing 12 months · +5.0% YoY

Ex-date	Per share
May 6, 2026	$0.4800
Feb 4, 2026	$0.4800
Oct 23, 2025	$0.4800
Jul 24, 2025	$0.4500
May 1, 2025	$0.4500
Feb 5, 2025	$0.4500
Oct 24, 2024	$0.4500
Jul 25, 2024	$0.4500
Apr 24, 2024	$0.4100
Jan 31, 2024	$0.4100
Oct 25, 2023	$0.4100
Jul 26, 2023	$0.4100
May 3, 2023	$0.3800
Feb 1, 2023	$0.3800
Oct 25, 2022	$0.3800
Jul 26, 2022	$0.3800
Apr 26, 2022	$0.3800
Feb 2, 2022	$0.3800
Oct 26, 2021	$0.3800
Aug 3, 2021	$0.3800
Apr 27, 2021	$0.3800
Jan 26, 2021	$0.3600
Oct 27, 2020	$0.3600
Jul 28, 2020	$0.3600